Introduction of Vivos Clinical Advisory Board

Vivos Therapeutics was founded in 2016 and looks to combine breakthrough technology for specially designed oral appliances along with proprietary clinical protocols for the treatment of obstructive sleep apnea (OSA) treatment which would restore and enhance the human airway. Due to its patented FDA Class I and II medical devices which are seen as the first treatment to address the root causes of OSA, Vivos is capable of improving the airway in such a way that additional clinical treatment would not be necessary for most cases.

Vivos is an ever growing company and recently introduced its Clinical Advisory Board earlier this year. This new board is chaired by Dr. Michael Bennett, DDS, and a diplomate of both the American Board of Craniofacial Pain and the American Board of Craniofacial Dental Sleep Medicine. Dr. Bennett is also the lead practitioner for the Vivos Breathing Wellness Center located in Orem, Utah. Dr. Dave Singh, the current president of Vivos Therapeutics, said, “Mike Bennett is uniquely qualified and experienced to chair this impressive team of clinicians and professionals.”

Another executive of the company, R. Kirk Huntsman who is the Chief Executive Officer of Vivos Therapeutics said, “given his years of practice focused on craniofacial pain and sleep breathing disorders such as obstructive sleep apnea, we’re very pleased to have Dr. Bennett heading up our clinical advisory board. His passion for clinical excellence in the treatment of this condition makes him the perfect leader for this new time.

When asked about his new position and the board as a whole, Dr. Michael Bennett has this to say, “our clinical advisory board will be an integral part of the success in delivering on the Vivos mission to provide powerful and innovative therapies that restore normal breathing during sleep, with the objective of bringing people back to a life full of vitality and happiness.”

Joining Dr. Bennett on this initial clinical advisory board will be the president, Dr. Dave Singh who is also an expert in craniofacial epigenetics along with Dr. Martha Cortes, DDS; Dr. Felix Liao; Dr. Chris Chapman, DC; Dr. Tammarie Heit, DDS; and Dr. Tara M. Griffin, DMD. All of these members of the board have numerous years of extensive clinical experience in treating obstructive sleep apnea.

Previous to this role as chairman of the clinical advisory board, Dr. Bennett served as a member of the company’s board of directors. For more information, please visit